DOCSLIB.ORG

ISMPP Publications Primer Working Group

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ISMPP Publications Primer Working Group ISMPP Publications Pri mer January 2016 A comprehensive single source overview of medical publications. TM Table of Contents Foreword ...................................................................................................................................... 5 Document Overview ................................................................................................................... 7 Key Terms ..................................................................................................................................... 9 Section 1: Publications 101 ..................................................................................................... 13 1.1 Peer Review............................................................................................................................................................. 13 1.2 Why Write And Submit A Manuscript? .................................................................................................... 14 1.3 Basic Publication Structure ........................................................................................................................... 16 1.4 How to Write Medical Publications ........................................................................................................... 18 1.5 Professional Assistance.................................................................................................................................... 21 1.6 Different Types of Publications ................................................................................................................... 22 Different types of manuscripts................................................................................................................................ 23 Other formats for journal publications ............................................................................................................... 26 Other types of medical publications ..................................................................................................................... 26 1.7 Different Types of Journals ............................................................................................................................ 28 1.8 Reporting Guidelines ......................................................................................................................................... 30 1.9 Submission Requirements.............................................................................................................................. 30 1.10 Reviewer’s Comments and Resubmission............................................................................................. 32 References for Section 1 .................................................................................................................................................. 32 Section 2: Compliance .............................................................................................................. 34 2.1 Comply With What? ............................................................................................................................................ 34 2.2 Why Comply? .......................................................................................................................................................... 34 © 2016 ISMPP 1 ISMPP Publications Pri mer January 2016 2.3 Compliance Guidelines ..................................................................................................................................... 35 International Committee of Medical Journal Editors .................................................................................... 35 Pharmaceutical Research and Manufacturers of America .......................................................................... 36 The European Federation of Pharmaceutical Industries and Associations ........................................ 36 International Society for Medical Publication Professionals ..................................................................... 36 2.4 Special Compliance Issues .............................................................................................................................. 37 2.5 Corporate Integrity Agreements................................................................................................................. 38 2.6 Sunshine Act............................................................................................................................................................ 38 2.7 Anti-Bribery and Corruption Laws ............................................................................................................ 39 2.8 Compliance Examples........................................................................................................................................ 41 2.9 International Compliance Guidance ......................................................................................................... 41 References for Section 2 .................................................................................................................................................. 43 Section 3: Ethics ......................................................................................................................... 45 3.1 Background ............................................................................................................................................................. 45 3.2 Publication Planning.......................................................................................................................................... 46 Publication steering committee.............................................................................................................................. 47 Trial disclosure and publication timing .............................................................................................................. 47 3.3 Publication Development................................................................................................................................ 50 Authorship responsibilities ...................................................................................................................................... 50 Use of a medical writer ............................................................................................................................................... 51 Referencing ...................................................................................................................................................................... 52 Acknowledgments ........................................................................................................................................................ 53 Disclosure ......................................................................................................................................................................... 53 Plagiarism......................................................................................................................................................................... 55 Permissions ..................................................................................................................................................................... 55 Retraction ......................................................................................................................................................................... 56 3.4 Other Legal Requirements For Sponsors And Authors.................................................................. 57 Sunshine Act .................................................................................................................................................................... 57 Anti-Bribery and Corruption laws ......................................................................................................................... 58 Corporate Integrity Agreements ............................................................................................................................ 59 References for Section 3 .................................................................................................................................................. 60 Section 4: Authorship ............................................................................................................... 61 4.1 Which Rules Apply? ............................................................................................................................................ 61 ICMJE authorship criteria .......................................................................................................................................... 61 Different interpretations of ICMJE criteria ........................................................................................................ 62 Acknowledgments ........................................................................................................................................................ 62 Guarantorship................................................................................................................................................................. 63 Transparency .................................................................................................................................................................. 64 Certified Medical Publication Professional
Load more

Recommended publications
  • Academic Search Complete
    Academic Search Complete Pavadinimas Prenumerata nuo Prenumerata iki Metai nuo Metai iki 1 Technology times 2021-04-01 2021-12-31 20140601 20210327 2 Organization Development Review 2021-04-01 2021-12-31 20190101 3 PRESENCE: Virtual & Augmented Reality 2021-04-01 2021-12-31 20180101 4 Television Week 2021-04-01 2021-12-31 20030310 20090601 5 Virginia Declaration of Rights and Cardinal Bellarmine 2021-04-01 2021-12-31 6 U.S. News & World Report: The Report 2021-04-01 2021-12-31 20200124 7 Education Journal Review 2021-04-01 2021-12-31 20180101 8 BioCycle CONNECT 2021-04-01 2021-12-31 20200108 9 High Power Computing 2021-04-01 2021-12-31 20191001 10 Economic Review (Uzbekistan) 2021-04-01 2021-12-31 20130801 11 Civil Disobedience 2021-04-01 2021-12-31 12 Appeal to the Coloured Citizens of the World 2021-04-01 2021-12-31 13 IUP Journal of Environmental & Healthcare Law 2021-04-01 2021-12-31 14 View of the Revolution (Through Indian Eyes) 2021-04-01 2021-12-31 15 Narrative of Her Life: Mary Jemison 2021-04-01 2021-12-31 16 Follette's Platform of 1924 2021-04-01 2021-12-31 17 Dred Scott, Plaintiff in Error, v. John F. A. Sanford 2021-04-01 2021-12-31 18 U.S. News - The Civic Report 2021-04-01 2021-12-31 20180928 20200117 19 Supreme Court Cases: The Twenty-first Century (2000 - Present) 2021-04-01 2021-12-31 20 Geophysical Report 2021-04-01 2021-12-31 21 Adult Literacy 2021-04-01 2021-12-31 2000 22 Report on In-Class Variables: Fall 1987 & Fall 1992 2021-04-01 2021-12-31 2000 23 Report of investigation : the Aldrich Ames espionage case / Permanent Select Committee on Intelligence,2021-04-01 U.S.
    [Show full text]
  • Indian S&T Journals in International Indexing and Abstracting Databases
    Annals of Library and Information Studies Vol. 59, December 2012, pp. 247-279 Indian S&T journals in international indexing and abstracting databases: A study Rabishankar Giri1, Prakash Chand2 and B K Sen3 1Indira Gandhi Institute of Technology, GGS Indraprastha University, Kashmere Gate, Delhi-110006, Email: [email protected], 2,aEx-Scientist, CSIR-National Institute of Science Communication and Information Resources, 14-Satsang Vihar Marg, New Delhi – 110067, Email: [email protected] 3,bFormer Visiting Professor, University of Malaya, Malaysia, Email: [email protected] The coverage of Indian science and technology (S&T) periodicals in major international indexing and abstracting (I&A) services has been studied. It is found that about 1200 Indian S&T journals are being covered by at least one of the international I&A services and over 300 S&T journals are openly accessible. However, coverage of Indian S&T journals by major citation databases, Web of Science (WoS) & Scopus is relatively poor. The newly launched Indian Citation Index (ICI) promises to cover more Indian journals. Keywords: Indian S&T journals, indexing & abstracting services, citation measure, impact factor Introduction Zoological Record, Excerpta Medica/Embase. India is the world's second fastest growing Medline, Index Copernicus, Mathematical Reviews, economy only next to China, with a large R & D Zentralblatt MATH, INIS, GeoBase along with two infrastructure. According to a recent report of Ernst & citation databases Scopus and Science Citation Index Young, India’s current higher education spending is Expanded (SCI-E) besides DOAJ to understand the estimated at Rs. 4,620 billion and projected to grow new open access phenomenon.
    [Show full text]
  • Medical Practice, Psychiatry and the Pharmaceutical Industry : and Ever the Trio Shall Meet
    The Academia - Industry Symposium Medical Practice, Psychiatry and the Pharmaceutical Industry : And Ever the Trio Shall Meet i The Academia - Industry Symposium Medical Practice, Psychiatry and the Pharmaceutical Industry : And Ever the Trio Shall Meet Ajai R. Singh, M.D. Shakuntala A. Singh Ph.D THE GOAL Mens Sana Research Foundation Mumbai, India iii ISSN 0973-1229 © Mens Sana Monographs (2005) Vol II, No. 6; Vol III, No.1-3, March 2005 - October 2005. Ajai R. Singh, M.D., Psychiatrist. Earlier, Hon. Editor, Psychology and Human Behaviour Digest, and Senior Research Fellow, WHO Collaborating Center in Psychopharmacology in India. Shakuntala A. Singh, Ph.D. Reader and Head, Department of Philosophy, Joshi- Bedekar College, Thane. Earlier, Fellow, Indian Council of Philosophical Research, New Delhi. Mens Sana Monographs are published bimonthly. This issue equals four regular issues. No part of this Monograph may be reproduced in any form without the written permission of the editors, except as brief quotations for the sake of scientific communication, and with due acknowledgment. About us The Mens Sana Monographs attempt to give in-depth understanding of Psychiatric/ Psychological/Philosophical consequences of social disorders / issues and current events, written in an easy to read format, avoiding technical jargon as far as possible, but based on evidence and research studies. Every monograph is to be followed by enlightened discussion on the issues raised by interested readers / scholars. You may forward your views / comments to the editors for incorporation, which may be suitably modified wherever necessary. The Mens Sana Monographs provide a wide platform for serious discussion by psychiatrists, social scientists, philosophers, psychologists, sociologists and other thinkers interested in exploring social issues with scientific rigour.
    [Show full text]
  • Attention Deficit Hyperactivity Disorder: a Reflection of Increased Medicalization in America? Schaeffer, Brooke 2020
    Lehigh Preserve Institutional Repository Attention Deficit Hyperactivity Disorder: A Reflection of Increased Medicalization in America? Schaeffer, Brooke 2020 Find more at https://preserve.lib.lehigh.edu/ This document is brought to you for free and open access by Lehigh Preserve. It has been accepted for inclusion by an authorized administrator of Lehigh Preserve. For more information, please contact [email protected]. Running Header: ADHD AND MEDICALIZATION IN AMERICA 1 Attention Deficit Hyperactivity Disorder: A Reflection of Increased Medicalization in America? Brooke Schaeffer Lehigh University BIOS 297, Professor Fink ADHD AND MEDICALIZATION IN AMERICA 2 Title: ADHD: A Reflection of Increased Medicalization in America? ​ Abstract: Medicalization in the United States has created more consistent classification and treatment guidelines for disorders and diseases nation-wide. However, the concept may foster a tendency toward premature diagnosis. The same can be said about pharmaceuticalization and quickness to medicate. Drug innovation and administration can be integral to quality of life, but how does this relationship shift when health becomes a commodity? How can the business end of medicine and pharmacy conflict with ethical responsibilities to patients? Here I utilize the increase in American Attention Deficit Hyperactivity Disorder diagnoses and psychostimulant prescriptions to illustrate potential repercussions of an increasingly medicalized and pharmaceuticalized society. I argue that the premature prescription of medication in response to rising ADHD diagnoses is an unethical course of treatment, thereby impeding the identification of the true causes underlying the symptoms and exposing the patient to unnecessary drug risks and side effects as a reflection of commercialized health. Introduction Over the past few decades, the number of Attention Deficit Hyperactivity Disorder (ADHD) diagnoses in America has increased significantly.
    [Show full text]
  • Assessment of Epidemiological Determinants of COVID-19 Pandemic Related to Social and Economic Factors Globally
    Journal of Risk and Financial Management Article Assessment of Epidemiological Determinants of COVID-19 Pandemic Related to Social and Economic Factors Globally Mohammad Mahmudul Hassan 1,* , Md. Abul Kalam 2 , Shahanaj Shano 3, Md. Raihan Khan Nayem 1 , Md. Kaisar Rahman 1,4 , Shahneaz Ali Khan 1 and Ariful Islam 4,5 1 Faculty of Veterinary Medicine, Chattogram Veterinary and Animal Sciences University, Chattogram 4225, Bangladesh; [email protected] (M.R.K.N.); [email protected] (M.K.R.); [email protected] (S.A.K.) 2 Helen Keller International, Dhaka 1212, Bangladesh; [email protected] 3 Institute of Epidemiology, Disease Control and Research, Dhaka 1212, Bangladesh; [email protected] 4 EcoHealth Alliance, New York, NY 10001, USA; [email protected] 5 Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Geelong, VIC 3216, Australia * Correspondence: [email protected] Received: 24 July 2020; Accepted: 28 August 2020; Published: 1 September 2020 Abstract: The COVID-19 pandemic has manifested more than a health crisis and has severely impacted on social, economic, and development crises in the world. The relationship of COVID-19 with countries’ economic and other demographic statuses is an important criterion with which to assess the impact of this current outbreak. Based on available data from the online platform, we tested the hypotheses of a country’s economic status, population density, the median age of the population, and urbanization pattern influence on the test, attack, case fatality, and recovery rates of COVID-19. We performed correlation and multivariate multinomial regression analysis with relative risk ratio (RRR) to test the hypotheses.
    [Show full text]
  • Inequality Report 2021: India's Unequal
    Inequality Report 2021: India’s Unequal Healthcare Story Acknowledgements I want to express my gratitude to all the people who made this report happen. It has benefited from extensive discussions with Amitabh Behar. Professor Amitabh Kundu provided critical inputs at various stages of the report as an expert guide, which greatly improved the quality of the report. Dr Pavitra Mohan, a public health expert who is currently associated with Aajeevika Bureau’s Amrit clinics, provided guidance in improving the analysis of the report as a peer reviewer. I would also like to thank our colleagues in Oxfam India—Anjela Taneja, Ankit Vyas, Agrima Raina, Akshay Tarfe, and Amita Pitre—for their review of the draft versions of the report. I also take this opportunity to thank Outline India for conducting the primary survey in seven states of India on behalf of Oxfam India. I thank Apoorva Mahendru, Mayurakshi Dutta, Pravas Ranjan Mishra, Sucheta Sardar, Khalid Khan and Vikrant Govardhan Wankhede for their contribution in authoring the report. I thank Diya Dutta for conceptualizing and guiding the team in developing the report. I also acknowledge the support of Priyanka Sarkar in editing the report and of Anandita Bishnoi for designing the report. I want to acknowledge and thank the Operations and the Public Engagement team members—Satya Prakash Mishra, Tejas Patel, Savvy Soumya Misra and Rahul Sharma—for the support provided by them. Ranu Kayastha Bhogal Commissioning Editor CONTENTS Foreword by Amitabh Behar 01 List of Figures 03 List of Tables 04
    [Show full text]
  • Mandatory Disclosure 2020-21
    CHAROTAR UNIVERSITY OF SCIENCE AND TECHNOLOGY (CHARUSAT) FACULTY OF MANAGEMENT STUDIES (FMS) INDUKAKA IPCOWALA INSTITUTE OF MANAGEMENT 2 (I IM) Mandatory Disclosure 2020-21 Mandatory Disclosure Updated on July 11, 2020. AICTE file No. Central/1-7011879849/2020/EOA Date & Time Period June 13, 2020. 1 Name of the Institution INDUKAKA IPCOWALA INSTITUTE OF MANAGEMENT Address of the Institution Education Campus AT PO: CHANGA TA: Petlad, DIST: Anand PIN:388421, CHANGA, ANAND, Gujarat, 388421, City & Pin Code Changa - 388421 State Gujarat Longitude & Latitude Longitude: 73. Latitude: 22 Phone No. 02697-247500 Fax No. 02697-247100 Office Hours at the Institution 9:00 am to 4:30 pm Academic hours at the 9:10 am to 4:20 pm Institution Email [email protected] Website www.charusat.ac.in Nearest Railway Station(dist. Nadiad Railway Station (11 Km) in km) Nearest Airport (dist. in km) Vadodara Airport (60 Km) Type of Institution Private- Self Financed Category (1) of the Institution Non Minority 2 Name and address of the SHREE CHAROTAR MOTI SATTAVIS Trust/ Society/ Company and PATIDAR KELAVANI MANDAL, ANAND the Trustees Type of organization Trust Address of the organization Vidhya Vihar Marg, B/H. Vaibhav Tower, Anand - Vidhyanagar Road, Anand Registered with Collector, Petlad Sub Registrar Registration Date 23/12/1998 3 Name of the Principal Prof. (Dr) Govind B Dave Exact Designation Principal Phone Number with STD code Mobile: +91-9099015370 Fax Number with STD code 02697-265007 Email [email protected] Highest Degree Ph. D. (Doctorate) Field of specialization Management 4 Name of the affiliating Charotar University of Science & University Technology CHARUSAT Campus-Changa Off.
    [Show full text]
  • Psychotherapy Model for the Training of Counselors in India
    National Louis University Digital Commons@NLU Dissertations 7-2020 Psychotherapy Model for the Training of Counselors in India Vini Kalra Follow this and additional works at: https://digitalcommons.nl.edu/diss Part of the Clinical Psychology Commons Recommended Citation Kalra, Vini, "Psychotherapy Model for the Training of Counselors in India" (2020). Dissertations. 444. https://digitalcommons.nl.edu/diss/444 This Dissertation - Public Access is brought to you for free and open access by Digital Commons@NLU. It has been accepted for inclusion in Dissertations by an authorized administrator of Digital Commons@NLU. For more information, please contact [email protected]. Running head: PSYCHOTHERAPY MODEL FOR INDIAN COUNSELORS Psychotherapy Model for the Training of Counselors in India Vini Kalra Mudita Rastogi, PhD Chair Carolyn Gralewski, PhD Member A Clinical Research Project submitted to the faculty at the Illinois School of Professional Psychology/National Louis University, Chicago Campus in partial fulfillment of the requirements for the degree of the Doctor of Psychology in Clinical Psychology Schaumburg, Illinois June, 2019 ISPP/ARGOSYUNIVERSITY, SCHAUMBURG CAMPUS ClinicalResearch Project Approval/Tracking Form \/ l NI lc_At- ......;.(<It- StudentID . StudentName ________ _______ lr£� Titleof� E�--�a�-� · 1-:::r 1 �j,� Chairperson (printname) /vfud; fa.. t2._�5 1 V [,__ · JJ . A +-u� 1. � r� /Jt,__ li. {)Co/;:;,�1 Chairperson(signature) ' � j Date f · ep mp g st STOP (Acopy of this trackingform with st #1 co letedis due toClinical Trainin by Navember1 ofthe third academicyear) 2• p�� Pl-.. .b. 1e/2.111i1 /j• e 1 Cha_i:rperson(signa _ f) V J Dat � (-N -I fY 2ndt_��;mfunber �.(signature) Date 3rd Committee member(optional) Date (A f STOP copyo thistracki ngform with step #2 completedis due to ClinicalTraining by June 1 ofthe thirdacademic year) 3.
    [Show full text]
  • JEMH Vol4 No1 Sept Supp
    JEMH INTRODUCTION INTRODUCTION he Journal of Ethics in Mental Health would like to warmly thank Dr. Richard Warner for Tinviting authors to contribute to this special supplement on the relationship between psychiatry and the pharmaceutical industry. We are also very grateful to Dr. Warner for contributing his guest editorial. Dr. Warner is Professor of Psychiatry and Adjunct Professor of Anthropology at the University of Colorado and an internationally recognized authority in a number of areas, including recovery from schizophrenia and social inclusion. He is well known for his comprehensive views of treatment and recovery and the range of issues that aff ect it, including the role of medications. Ron Ballantyne MSW MBA Editor-in-Chief e-mail: [email protected] JEMH · April 2009 · 4(Sept. Suppl.) | 1 © 2009 Journal of Ethics in Mental Health (ISSN: 1916-2405) GUEST EDITORIAL Ethical Problems in the Relationship of Psychiatry to the Pharmaceutical Industry Richard Warner, M.B., D.P.M. Director, Colorado Recovery Clinical Professor, University of Colorado, USA sychiatry and the pharmaceutical industry have in the “off -label” promotion of medication use, industry been embarrassed by U.S. senate hearings and a control of research priorities, bias in reporting research Pseries of articles in the New York Times revealing results, the “ghostwriting” of research articles and the that a number of prominent psychiatrists have failed to involvement of industry in the ongoing education of report signifi cant fi nancial confl icts of interest.
    [Show full text]
  • IJDIT Journal 6.4.Cdr
    ISSN 2229-5984 (P) 2249-5576 (e) Ranking and Comparison of Journals Published in India with Special Reference to Humanities and Social Sciences Nanjundaiah* and Dinesh, K. S. ** To Cite: Nanjundaiah & Dinesh, K. S. (2016). Ranking and Comparison of Journals Published in India with Special Reference to Humanities and Social Sciences. International Journal of Information Dissemination and Technology, 6(4), 251-257. *Librarian, Gokhale Centenary ABSTRACT College, Ankola, Karnataka, This paper describes the subject-wise distribution and ranking of HSS journals Research Scholar, published in India with the help of SCImago Journal Ranking (SJR). The paper compares the ranking of journals published in India with international level journals DLIS, Bharathiar University, using SJR. The paper reveals that in seven subject areas, journals published from Coimbatore India are nowhere comparable at the international level publications. In **Deputy Librarian, multidisciplinary area, only journal from India is in 5th position at international level. Indian Institute of Technology, The paper also bring out the fact that most of the top ranked journals at international Ropar level have been published from United States or United Kingdom. Corresponding Author Dinesh K. Siddaiah KeyTerms:Journals ranking, SJR Indicator, SNIP, IPP, Humanities and Social Science Journals, Scientometric Analysis [email protected] Received on: 09.07.16; Revised on: 17.11.16; Accepted on: 05.12.16 INTRODUCTION Reports (JCR) and SCImago Journal Rank (SJR) indicator. SJR was developed by SCImago from the widely known algorithm Google Analyzing the ranking and comparing the journals at the Page Rank. This indicator shows the visibility of the journals international level is very important for the researchers, funding contained in the Scopus database from 1996.
    [Show full text]
  • Impact on Mental Health
    Sanjana Arora ________________________________ Autonomy and Marriage: Impact on Mental health A study on local Indian women in India and Indian immigrant women in Norway Oslo and Akershus University College of Applied Sciences, Faculty of Social Sciences Abstract This thesis aims to understand the factors that contribute to poor mental health among local Indian women living in India and Indian immigrant women living in Norway. By focusing on the interplay of marriage and autonomy in Indian society, I aim to understand how the women experience autonomy, and the impact of it, on mental health. Moreover, since these women come from a collectivist society with traditionally entrenched gender roles and high emphasis on relatedness, we also consider how they negotiate restricted autonomy. Although the two groups of women come from different educational, family backgrounds and live in different societies now, they are related through shared bonds of gender and experiences of belonging to a patriarchal society. By taking them simultaneously, I aim to enrich reflections about men- tal health issues in lives of Indian women. In addition to this, the study aims to understand what coping strategies women adopt when experiencing mental health difficulties and why. Furthermore, owing to the gap between prevalence of mental health problems and professional help seeking among Indian women, it becomes imperative to understand these women’s perception towards professional help seek- ing and thus this study aims to understand the same. I used Postcolonial feminist perspective to look at gender, ethnicity, cultural, social- economic-historical-political factors and their relationship with mental well-being while ad- dressing all aims of the study.
    [Show full text]
  • Annual Report 2007 Faculty of Medicine, Dentistry and Health Sciences
    Melbourne School of Population Health Annual Report 2007 Faculty of Medicine, Dentistry and Health Sciences Melbourne School of Population Health Annual report 2007 MSPH SUMMARY REPORT 1 CENTRE FOR MEGA EPIDEMIOLOGY 25 CENTRE FOR HEALTH & SOCIETY 33 KEY CENTRE FOR WOMEN’S HEALTH IN SOCIETY 37 McCAUGHEY CENTRE 47 CENTRE FOR HEALTH POLICY, PROGRAMS & ECONOMICS 61 CENTRE FOR INTERNATIONAL MENTAL HEALTH 79 SEXUAL HEALTH UNIT 83 VACCINE AND IMMUNISATION RESEARCH GROUP 89 Faculty of Medicine, Dentistry and Health Sciences Melbourne School of Population Health MSPH Summary Report 2007 Overview Message from the The Melbourne School of Population Health’s vision is to inculcate Head Of School a population health approach in all areas of health care and in the community where opportunities for disease and injury prevention exist. What is population health? Population health is an approach to health that aims to improve the health of the entire population and to reduce health inequities among population groups. The study of population health is focused on understanding health and disease in the community, and on improving health and well- being through priority health approaches addressing the disparities in health status between social groups (Australian Institute for Health and Terry Nolan, Welfare). Head of Melbourne School of Population Health Our Mission 2007 proved to be another significant To conduct and enhance research that addresses issues of population year of developments for the Melbourne health and health social sciences, and to educate undergraduates and School of Population Health. The School has been actively engaged in the postgraduate students, clinicians, scientists, professionals and public development of the Melbourne Model and health leaders through the enrichment of our educational programs in the University’s Growing Esteem Strategy.
    [Show full text]